arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

Target Group Inc.

CBDY
— Price unavailable
Materials ·Medicinal Chemicals & Botanical Products ·USMedicinal Chemicals & Botanical Products
13 Visible periods
27 Metrics
Peer-ranked Benchmarks
Price Chart
59
Health
Fair
Neutral
auto_awesome

Analytical Summary

Target Group Inc. demonstrates solid fundamentals with strength in Return on Common Equity (%). However, watch Profit Margin (%) which shows concerning trends. Overall, the data suggests a moderately positive outlook with manageable risks.

Market Cap —
Dividend Yield —
Revenue Growth -41.1% ↘
Op. Margin —
ROIC —
FCF / Share $-0.00 ↘
Trailing P/E —
Price / Book —
FCF Yield —
Debt / Equity -0.94
info Valuation on last close.

13-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$3.88M
↓ -41.1% —
Net Income Profit after all expenses
$-1.36M
↓ -947.1% —
FCF / Share Free cash flow per share
$-0.00
↓ -139.0% —
Long-Term Debt Long-term obligations
$7.60M
↓ -3.5% —
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↓
8
Returns
83
Financial Health
100
Cash Quality ↑
45

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 13 years · 54 quarters